MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MAES, V.
Right arrow Articles by KANAREK, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAES, V.
Right arrow Articles by KANAREK, L.

Molecular Pharmacology, Vol 16, 147-153, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Optical Studies into the Nature of the High Affinity Binding Site of Human Serum Albumin for Phenylbutazone

VIVIANE MAES 1, JOHAN HOEBEKE 1, ANTOINE VERCRUYSSE 1, and LOUIS KANAREK 1

1 Afdelingen Farmacognosie, Fytochemie en Toxicologie, Pathologische Biochemie en Chemie der Proteïnen, Faculteit Geneeskunde en Farmacie en Institut voor Molekulaire Biologie, Vrije Universiteit Brussel, Paardentraat 67, B-1640 Sint-Genesius-Rode

The binding of phenylbutazone to human serum albumin was investigated by UV difference-spectroscopy. From these measurements at two different wavelengths an association constant of 6.5 x 105 M-1 at 27.5° was calculated. The intrinsic tryptophan fluorescence of human serum albumin was quenched by binding of phenylbutazone. This quenching was not due to absorption or nonradiative energy transfer, but to a direct perturbation of the molecular environment of the fluorophore. Fluorescence measurements allowed us to calculate the binding parameters of the phenylbutazone-albumin interaction and to evaluate the thermodynamics of the binding. The association constant varied from 6.2 to 9.5 x 105 M-1 at temperatures from 18° to 45° corresponding with free energy changes from -7.7 to -8.7 kcal/mole. The reaction is endothermic (DgrH = +3.0 kcal/mole) and strongly entropy-driven (DgrS = +36.8 e.u.). This is characteristic for a hydrophobic interaction with solvent perturbation. Spectrophotometric and fluorescence measurements both suggested that upon binding, phenylbutazone forms a pgr-pgr complex with the tryptophan residue of the protein. This points toward the presence of that residue in the high affinity binding site. Yet the alternative hypothesis of a conformational change in the protein causing the optical changes could not be definitely excluded.

Submitted on June 12, 1978
Accepted on December 28, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics